- Previous Close
1.780 - Open
1.780 - Bid 1.740 x --
- Ask 1.760 x --
- Day's Range
1.730 - 1.780 - 52 Week Range
0.860 - 2.090 - Volume
456,000 - Avg. Volume
838,515 - Market Cap (intraday)
1.416B - Beta (5Y Monthly) 0.16
- PE Ratio (TTM)
8.70 - EPS (TTM)
0.200 - Earnings Date --
- Forward Dividend & Yield 0.11 (6.32%)
- Ex-Dividend Date Dec 17, 2024
- 1y Target Est
2.42
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.
www.jbmhealthcare.com.hk279
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: 2161.HK
View MorePerformance Overview: 2161.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2161.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2161.HK
View MoreValuation Measures
Market Cap
1.42B
Enterprise Value
1.35B
Trailing P/E
8.91
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.03
Price/Book (mrq)
1.40
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
6.43
Financial Highlights
Profitability and Income Statement
Profit Margin
22.74%
Return on Assets (ttm)
8.54%
Return on Equity (ttm)
16.25%
Revenue (ttm)
720.54M
Net Income Avi to Common (ttm)
163.88M
Diluted EPS (ttm)
0.200
Balance Sheet and Cash Flow
Total Cash (mrq)
189.67M
Total Debt/Equity (mrq)
8.32%
Levered Free Cash Flow (ttm)
205.48M